Phase I Study of Trifluridine/tipiracil (TAS-102) Plus Irinotecan in Combination with Bevacizumab As a Second-Line Therapy for Patients with Metastatic Colorectal Cancer

Jing Zhang,Wenwei Yang,Junbao Liu, Nan Wang, Zhaoying Ren, Tingting Yang, Gongli Xie,Guifu Wu,Yongkun Sun

INVESTIGATIONAL NEW DRUGS（2024）

引用 0|浏览0

暂无评分

关键词

Metastatic colorectal cancer (mCRC),Second-line therapy,Trifluridine/tipiracil (TAS-102),Bevacizumab,Irinotecan

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要